逆境中的弹性:探索在压力下癌细胞的适应性变化
Taissa Dos Santos Uchiya1, Helena Napoli da Cunha1, Matheus Correia Casotti1
1Núcleo de Genética Humana e Molecular (NGHM), Federal University of Espírito Santo (UFES), Espírito Santo, Brazil.
Tissue & cell
|January 26, 2025
概括
癌细胞通过形态和遗传变化适应压力,增强生存,增殖和入侵. 这些适应性,包括表皮细胞-介质细胞过渡和多重化,促进瘤发生和治疗耐药性,建议新的治疗点.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 癌细胞表现出适应机制,在各种细胞应激下生存和繁殖.
- 这些适应性与关键的致癌过程,如遗传不稳定性,瘤生长和对疗法的耐药性密切相关.
研究的目的:
- 审查现有的关于新生细胞因压力条件而产生的形态和遗传变化的研究.
- 了解癌细胞如何适应生存和促进在压力下瘤发生.
主要方法:
- 使用主要科学数据库 (PubMed,科学网,CAPES,BVS,Scopus) 进行了文章的综合性审查.
- 包括了专注于癌细胞的形态遗传变化作为应激适应反应的研究.
主要成果:
- 审查了82项研究,详细介绍了癌细胞的各种压力:氧化,热,机械,营养缺乏,缺氧和化疗.
- 新生细胞通过形态变化 (上皮-半机体过渡,多重化,线粒体/细胞骨变化) 和遗传突变适应压力.
- 这些适应性变化与增加的遗传不稳定性,瘤增殖,治疗耐药性和入侵相关.
结论:
- 细胞应激适应驱动形态和功能变化,加速瘤发生.
- 皮质 - 介质细胞过渡,多化和线粒体功能障碍增强瘤细胞存活率,治疗耐药性和侵入性.
- 在压力下基因组不稳定性和细胞衰老有助于瘤异质性,耐药性和进展,突出潜在的治疗点和生物标志物.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
Psychoneuroimmunology: Diabetes and Cancer
22
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
22
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer
47.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.7K
Cancers Originate from Somatic Mutations in a Single Cell
11.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.5K


